Synthetic Drug Control Act of 2017

To amend the Controlled Substances Act to add certain synthetic substances to schedule I, and for other purposes. 1. Short title This Act may be cited as the Synthetic Drug Control Act of 2017 2. Treatment of certain designer drugs as schedule I controlled substances (a) In general Not later than 180 days after the date of enactment of this Act, the Attorney General of the United States shall update schedule I under section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c) (1) Phenylalkylamines The substances listed in this paragraph consist of the following phenylalkylamines: (A) 1-(4-Ethylphenyl)-2-(methylamino)-1-propanone. (B) 1-(4-Methoxyphenyl)-2-(methylamino)-1-propanone. (C) 2-(Ethylamino)-1-(4-methoxyphenyl)-1-propanone. (D) 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)-1-propanone. (E) 2-(Ethylamino)-1-phenyl-1-propanone. (F) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone. (G) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone. (H) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-propanone. (I) 2-Amino-1-(4-fluorophenyl)propan-1-one. (J) 2-(Ethylamino)-1-(4-ethylphenyl)-1-propanone. (K) 2-(Dimethylamino)-1-phenyl-1-propanone. (L) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-butanone. (M) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-hexanone. (N) 2-(Methylamino)-1-phenyl-1-butanone. (O) 2-(Methylamino)-1-(4-methylphenyl)-1-butanone. (P) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-butanone. (Q) 1-(3,4-Dimethylphenyl)-2-(methylamino)-1-propanone. (R) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-propanone. (S) 2-(Benzylamino)-1-(4-methylphenyl)-1-propanone. (T) 1-(1-Naphthyl)-2-(1-pyrrolidinyl)-1-pentanone. (U) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-propanone. (V) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-butanone. (W) 1-(1,3-Benzodioxol-2-yl)-2-(N-hydroxy-N-methylamino)-1-propanone. (X) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-butanone. (Y) 2-(Ethyl(methyl)amino)-1-phenylbutan-1-one. (Z) 1-(4-Bromophenyl)-2-(methylamino)-1-propanone. (AA) 2-[Ethyl(methyl)amino]-1-phenyl-1-propanone. (BB) 2-(Methylamino)-1-(3-methylphenyl)-1-propanone. (CC) 2-(1-Pyrrolidinyl)-1-(2-thiophenyl)-1-pentanone. (DD) 1-(4-Fluorophenyl)-2-(methylamino)-1-butanone. (EE) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-butanone. (FF) 1-(4-Ethylphenyl)-2-(1-pyrrolidinyl)-1-butanone. (GG) 1-(4-Methoxy-3-methylphenyl)-2-(methylamino)-1-propanone. (HH) 2-(Ethylamino)-1-(3-methylphenyl)-1-propanone. (II) 2-Amino-1-(1H-indol-5-yl)-1-propanone. (JJ) 1-Phenyl-2-(1-piperidinyl)-1-butanone. (KK) 2-(Methylamino)-1-(2,4,5-trimethylphenyl)-1-propanone. (LL) 1-Phenyl-2-(1-pyrrolidinyl)-1-heptanone. (MM) 1-Phenyl-2-(1-pyrrolidinyl)-1-hexanone. (NN) 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone. (OO) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-pentanone. (PP) 1-(2-Fluorophenyl)-N-methyl-2-propanamine. (QQ) 1-(2-Fluorophenyl)-2-propanamine. (RR) 1-(3-Fluorophenyl)-2-propanamine. (SS) 1-(3-Fluorophenyl)-N-methyl-2-propanamine. (TT) 1-(4-Fluorophenyl)-2-propanamine. (UU) 1-(4-Fluorophenyl)-N-methyl-2-propanamine. (VV) 1-(4-Methylphenyl)-2-propanamine. (WW) N-Ethyl-N-methyl-1-phenyl-2-propanamine. (XX) 1-(1-Benzofuran-4-yl)-2-propanamine. (YY) 1-(1-Benzofuran-5-yl)-2-propanamine. (ZZ) 1-(2,3-Dihydro-1-benzofuran-5-yl)-2-propanamine. (AAA) 1-(1-Benzofuran-6-yl)-2-propanamine. (BBB) 1-(2,3-Dihydro-1-benzofuran-6-yl)-2-propanamine. (CCC) 1-(4-Methoxyphenyl)-N-methyl-2-propanamine. (DDD) N,N-Dimethyl-1-phenyl-2-propanamine. (EEE) 1-(2,3-Dihydro-1H-inden-5-yl)-2-propanamine. (FFF) 5,6,7,8-Tetrahydronaphtho[2,3-d][1,3]dioxol-6-amine. (GGG) 1-[4-(Methylsulfanyl)phenyl]-2-propanamine. (HHH) 1-(4-Chlorophenyl)-2-propanamine. (III) 1-(2,4,6-Trimethoxyphenyl)-2-propanamine. (JJJ) 1-(2,4,5-Trimethoxyphenyl)-2-propanamine. (KKK) 1-(2,5-Dimethylphenyl)-2-propanamine. (LLL) 1-(3,4-Dimethylphenyl)-2-propanamine. (MMM) N-(1-Phenyl-2-propanyl)-1-propanamine. (NNN) 1-(1,3-Benzodioxol-5-yl)-N,N-dimethyl-2-propanamine. (OOO) N-Ethyl-1-(4-methoxyphenyl)-2-propanamine. (PPP) 1-(1-Benzofuran-5-yl)-N-methyl-2-propanamine. (QQQ) 6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine. (RRR) 5-Iodo-2-indanamine. (SSS) N-Methyl-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine. (TTT) N-Methyl-2-indanamine. (UUU) 2-{4-[(2-Fluoroethyl)sulfanyl]-2,5-dimethoxyphenyl}ethanamine. (VVV) 2-(8-Bromo-2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran-4-yl)ethanamine. (WWW) 2-(2,5-Dimethoxy-3,4-dimethylphenyl)ethanamine. (XXX) 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine. (YYY) 2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. (ZZZ) 2-(2,5-Dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl)ethanamine. (AAAA) 2-(2,5-Dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine. (BBBB) 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethanamine. (CCCC) 1-(8-Bromofuro[2,3-f][1]benzofuran-4-yl)-2-propanamine. (DDDD) 1-(4-Chloro-2,5-dimethoxyphenyl)-2-propanamine. (EEEE) 1-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b′]difuran-4-yl)propan-2-amine. (FFFF) 1-[4-(Ethylsulfanyl)-2,5-dimethoxyphenyl]-2-propanamine. (GGGG) 1-(4-Ethoxy-2,5-dimethoxyphenyl)-2-propanamine. (HHHH) 1-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-2-propanamine. (IIII) 6-Chloro-1,2,3,4-tetrahydro-1-naphthalenamine. (JJJJ) N-Methyl-3-phenylbicyclo[2.2.1]heptan-2-amine. (KKKK) 1-(2-Methoxyphenyl)-N-methyl-2-propanamine. (LLLL) 2-[4-(Allyloxy)-3,5-dimethoxyphenyl]ethanamine. (MMMM) 4-Methyl-2-hexanamine. (NNNN) 4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine. (OOOO) N-Methyl-1-(2-thienyl)-2-propanamine. (PPPP) 3-(Dimethylamino)-2,2-dimethylpropyl 4-aminobenzoate. (QQQQ) 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine. (RRRR) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanol. (2) Cannabimimetic agents The substances listed in this paragraph consist of the following cannabimimetic agents: (A) (4-Ethyl-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (B) 2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone. (C) (2-Methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-nitro-1H-indol-3-yl)(2-naphthyl)methanone. (D) (1-Butyl-1H-indol-3-yl)(4-methoxyphenyl)methanone. (E) (1-Butyl-1H-indol-3-yl)(4-methyl-1-naphthyl)methanone. (F) [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methyl-1-naphthyl)methanone. (G) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-yl}(1-naphthyl)methanone. (H) 2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone. (I) (2-Iodophenyl){1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl}methanone. (J) Adamantan-1-yl{1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl}methanone. (K) 1-Naphthyl(1-propyl-1H-indol-3-yl)methanone. (L) 5-[3-(1-Naphthoyl)-1H-indol-1-yl]pentanenitrile. (M) 3-(1-Naphthylmethyl)-1-pentyl-1H-indole. (N) (2-Methyl-1-propyl-1H-indol-3-yl)(1-naphthyl)methanone. (O) 1-Naphthyl[1-(4-penten-1-yl)-1H-indol-3-yl]methanone. (P) (4-Bromo-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (Q) (4-Fluoro-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (R) (1-Naphthyl)(1-phenyl-1H-indol-3-yl)methanone. (S) [1-(5-Chloropentyl)-1H-indol-3-yl](2-iodophenyl)methanone. (T) Adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone. (U) (2-Iodo-5-nitrophenyl){1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl}methanone. (V) {1-[2-(4-Morpholinyl)ethyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone. (W) [1-(Tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (X) N-(Adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide. (Y) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (Z) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (AA) [1-(3-Methylbutyl)-1H-indol-3-yl](1-naphthyl)methanone. (BB) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide. (CC) (1-Pentyl-1H-indol-3-yl)(4-propyl-1-naphthyl)methanone. (DD) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (EE) (4-Methyl-1-naphthyl)[1-(4-penten-1-yl)-1H-indol-3-yl]methanone. (FF) (2-Methoxy-1-naphthyl)(1-pentyl-1H-indol-3-yl)methanone. (GG) (3-Methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone. (HH) (4-Ethyl-1-naphthyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone. (II) 8-Quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate. (JJ) 1-(5-Fluoropentyl)-N-(1-naphthyl)-1H-indole-3-carboxamide. (KK) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide. (LL) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-pentyl-1H-indole-3-carboxamide. (MM) (2-Iodophenyl)(1-pentyl-1H-indol-3-yl)methanone. (NN) [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl](1-naphthyl)methanone. (OO) N-(1-Naphthyl)-1-pentyl-1H-indole-3-carboxamide. (PP) [1-(5-Chloropentyl)-1H-indol-3-yl](4-methyl-1-naphthyl)methanone. (QQ) (4-Methyl-1-naphthyl)(2-methyl-1-pent-4-enyl-1H-indol-3-yl)methanone. (RR) (2-Methylphenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone. (SS) (2-Ethylphenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]methanone. (TT) [1-(5-Chloropentyl)-1H-indol-3-yl](1-naphthyl)methanone. (UU) [1-(5-Bromopentyl)-1H-indol-3-yl](1-naphthyl)methanone. (VV) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone. (WW) [1-(1-Methylazepan-2-yl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (XX) 4-Hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)-1-pentanone. (YY) [1-(4-Fluoropentyl)-1H-indol-3-yl](1-naphthyl)methanone. (ZZ) 2-(2-Iodophenyl)-1-(1-pentyl-1H-indol-3-yl)-1-ethanone. (AAA) (2,2,3,3-Tetramethylcyclopropyl)(1-butyl-1H-indol-3-yl)methanone. (BBB) (2,2,3,3-Tetramethylcyclopropyl)[1-(4,4,4-trifluorobutyl)-1H-indol-3-yl]methanone. (CCC) 7-Methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3 -carboxamide. (DDD) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate. (EEE) 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate. (FFF) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (GGG) [1-(4-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (HHH) 1-Naphthyl(1-pentyl-1H-indazol-3-yl)methanone. (III) N-(1-Naphthyl)-1-pentyl-1H-indazole-3-carboxamide. (JJJ) 1-Naphthyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. (KKK) Methyl 3-methyl-2-[(1-pentylindazole-3-carbonyl)amino]butanoate. (LLL) Methyl 2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3-methylbutanoate. (MMM) N-Benzyl-1-pentyl-1H-indole-3-carboxamide. (NNN) N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (OOO) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate. (PPP) 8-Quinolinyl 1-pentyl-1H-indazole-3-carboxylate. (QQQ) 8-Quinolinyl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate. (RRR) 2-Naphthyl 1-(2-fluorophenyl)-1H-indazole-3-carboxylate. (SSS) [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone. (TTT) 2-{[1-(5-Fluoropentyl)-1H-indol-3-yl]formamido}-3-phenylpropanamide. (UUU) 2-{[1-(5-Fluoropentyl)-1H-indazol-3-yl]formamido}-3-phenylpropanamide. (VVV) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3-methylbutanoate. (WWW) Methyl 2-[[1-(Cyclohexylmethyl)indazole-3-carbonyl]amino]-3,3-dimethylbutanoate. (XXX) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-yl]formamido}-3,3-dimethylbutanoate. (YYY) [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](1-naphthyl)methanone. (ZZZ) [1-(4-Fluorobenzyl)-1H-indol-3-yl](1-naphthyl)methanone. (AAAA) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3,3-dimethylbutanoate. (BBBB) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indazole-3-carboxylate. (CCCC) N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide. (DDDD) N-(1-Amino-3-methyl-1-oxo-2-butanyl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide. (EEEE) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-2-heptanyl)phenol. (FFFF) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-2-dodecanyl)phenol. (GGGG) 3-Hydroxy-2-[(1R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone. (HHHH) {4-[2,6-Dimethoxy-4-(2-methyl-2-octanyl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol. (IIII) 1-Naphthyl[4-(pentyloxy)-1-naphthyl]methanone. (JJJJ) 3-{[2-(Hydroxymethyl)-2,3-dihydro-1H-inden-4-yl]oxy}phenyl 4,4,4-trifluoro-1-butanesulfonate. (KKKK) N-(1,3-Benzodioxol-5-ylmethyl)-7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarboxamide. (LLLL) N-[3-(2-Methoxyethyl)-4,5-dimethyl-2,3-dihydro-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropa ne-1-carboxamide. (MMMM) [5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-yl](1-naphthyl)methanone. (NNNN) 5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide. (OOOO) 6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one. (PPPP) 4-Hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-3-(pentylamino)benzamide. (3) Arylcyclohexamines The substances listed in this paragraph consist of the following arylcyclohexamines: (A) 1-(3-Methoxyphenyl)-N-propylcyclohexanamine. (B) 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexanone. (C) 1-Phenylcyclohexanamine. (D) 1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine. (E) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine. (F) 1(4-Methoxyphenyl)-N-propylcyclohexanamine. (G) 1-[1-(4-Methoxyphenyl)cyclohexyl]piperidine. (H) 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine. (I) 1-Phenyl-N-propylcyclohexanamine. (J) N-(2-Methoxyethyl)-1-phenylcyclohexanamine. (K) N-(2-Ethoxyethyl)-1-phenylcyclohexanamine. (L) N-(3-Methoxypropyl)-1-phenylcyclohexanamine. (M) 3-[1-(1-Piperidinyl)cyclohexyl]phenol. (N) 2-(4-Methoxyphenyl)-2-(methylamino)cyclohexanone. (O) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexanone. (4) Tryptamines The substances listed in this paragraph consist of the following tryptamines: (A) 2-(1H-Indol-3-yl)-N-methylethanamine. (B) N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-2-propanamine. (C) N-[2-(1H-Indol-3-yl)ethyl]-N-isopropyl-2-propanamine. (D) N-[2-(1H-Indol-3-yl)ethyl]-N-propyl-1-propanamine. (E) 3-(2-(Diethylamino)ethyl)-1H-indol-4-yl acetate. (F) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-ol. (G) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-yl acetate. (H) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-yl acetate. (I) 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl acetate. (J) 3-[2-(Diethylamino)ethyl]-1H-indol-4-ol. (K) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-ol. (L) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-ol. (M) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl acetate. (N) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-ol. (O) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-yl acetate. (P) N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-N-methylpropan-2-amine. (Q) 1-(5-Methoxy-1H-indol-3-yl)-2-propanamine. (R) 3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl acetate. (S) N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-2-amine. (T) N,N-Diethyl-2-(5-methoxy-1H-indol-3-yl)ethanamine. (U) N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethanamine. (5) Benzylpiperidines The substances listed in this paragraph consist of the following benzylpiperidines: (A) 2-(Diphenylmethyl)piperidine. (B) 2-(Diphenylmethyl)pyrrolidine. (C) Diphenyl(2-pyrrolidinyl)methanol. (D) Methyl (3,4-dichlorophenyl)(2-piperidinyl)acetate. (E) Methyl (3-chlorophenyl)(2-piperidinyl)acetate. (F) Methyl (4-methylphenyl)(2-piperidinyl)acetate. (G) Methyl (4-fluorophenyl)(2-piperidinyl)acetate. (H) Ethyl phenyl(2-piperidinyl)acetate. (6) Benzodiazepines The substances listed in this paragraph consist of the following benzodiazepines: (A) 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. (B) 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one. (C) 8-Bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine. (D) 3-Methyl-6-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazine. (7) Opioids and opioid-like substances The substances listed in this paragraph consist of the following opioids and opioid-like substances: (A) 3-[2-(2-Amino-2-propanyl)-1-hydroxycyclohexyl]phenol. (B) 2-Methyl-N-phenyl-N-[1-(1-phenyl-2-propanyl)-4-piperidinyl]propanamide. (C) 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine. (D) N-Phenyl-N-[1-(2-thiophenylethyl)-4-piperidinyl]acetamide. (8) Piperazines The substances listed in this paragraph consist of the following piperazines: (A) 1,4-Dibenzylpiperazine. (B) 1-(4-Bromo-2,5-dimethoxybenzyl)piperazine. (C) 1-(4-Fluorophenyl)piperazine. (D) 1-(2-Methoxyphenyl)piperazine. (E) 1-(4-Chlorophenyl)piperazine. (F) 1-(4-Methoxyphenyl)piperazine. (G) 1-(3-Methylbenzyl)piperazine. (H) 1-Benzyl-4-methylpiperazine. (9) Tropane and alkaloids The substances listed in this paragraph consist of the following tropane alkaloids: (A) 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoate. (B) Methyl 3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate. (b) Inapplicability of other process and considerations The Attorney General of the United States may carry out subsection (a) without regard to the process and considerations that are otherwise applicable under section 201 of the Controlled Substances Act ( 21 U.S.C. 811 21 U.S.C. 812(c) (c) Exemption for research (1) Exemption Notwithstanding subsection (a), a material, compound, mixture, or preparation described in such subsection shall not be treated as a controlled substance for purposes of the Controlled Substances Act ( 21 U.S.C. 801 (2) Qualified research defined In this subsection, the term qualified research 21 U.S.C. 823(f) (d) Rule of construction Nothing in this section shall be construed to limit or affect the authority of the Attorney General of the United States to add, remove, or transfer controlled substances to, from, or among the schedules under section 202(c) of the Controlled Substances Act ( 21 U.S.C. 812(c)

Summary: Synthetic Drug Control Act of 2017 This bill directs the Drug Enforcement Administration to update schedule I of the Controlled Substances Act to include certain synthetic substances. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. The bill exempts from treatment as a controlled substance any such synthetic substance that is manufactured, distributed, and used exclusively for research.